Inclusion body formation, macroautophagy, and the role of HDAC6 in neurodegeneration

Acta Neuropathologica

Volumn 126, Issue 6, 2013, Pages 793-807

  Richter Landsberg, Christiane ^a   Leyk, Janina ^a  

^a UNIVERSITY OF OLDENBURG   (Germany)

Author keywords

LC3; Microtubules; P62 sequestosome 1; Protein aggregates; Tau protein; Ubiquitin

Indexed keywords

CELL PROTEIN; HISTONE DEACETYLASE 6; TAU PROTEIN; TUBULIN; UBIQUITINATED PROTEIN;

ACETYLATION; AGGRESOME; AUTOPHAGOSOME; AUTOPHAGY; CELL INCLUSION; CELL ORGANELLE; CYTOPLASM; DEGENERATIVE DISEASE; HUMAN; LEWY BODY; LYSOSOME; MACROAUTOPHAGY; NERVE DEGENERATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; QUALITY CONTROL; REVIEW; SHY DRAGER SYNDROME;

ANIMALS; AUTOPHAGY; BRAIN; HISTONE DEACETYLASES; HUMANS; INCLUSION BODIES; LEWY BODIES; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES;

EID: 84892611793     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-013-1158-x     Document Type: Review

References (150)

1. Aldana-Masangkay GI, Sakamoto KM (2011) The role of HDAC6 in cancer. J Biomed Biotechnol 2011:875824. doi:10.1155/2011/875824
2. Ardley HC, Hung CC, Robinson PA (2005) The aggravating role of the ubiquitin-proteasome system in neurodegeneration. FEBS Lett 579(3):571-576. doi:10.1016/j.febslet.2004.12.058
3. Bali P, Pranpat M, Bradner J, Balasis M, Fiskus W, Guo F, Rocha K et al (2005) Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors. J Biol Chem 280(29):26729-26734. doi:10.1074/jbc.C500186200
4. Ballatore C, Brunden KR, Huryn DM, Trojanowski JQ, Lee VM, Smith AB III (2012) Microtubule stabilizing agents as potential treatment for Alzheimer's disease and related neurodegenerative tauopathies. J Med Chem 55(21):8979-8996. doi:10.1021/jm301079z
5. Ballatore C, Lee VM, Trojanowski JQ (2007) Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci 8(9):663-672. doi:10.1038/nrn2194
6. Bauer NG, Richter-Landsberg C (2006) The dynamic instability of microtubules is required for aggresome formation in oligodendroglial cells after proteolytic stress. J Mol Neurosci 29(2):153-168. doi:10.1385/JMN:29:2:153
7. Behl C (2011) BAG3 and friends: co-chaperones in selective autophagy during aging and disease. Autophagy 7(7):795-798. doi:10.4161/auto.7.7.15844
8. Bertos NR, Gilquin B, Chan GK, Yen TJ, Khochbin S, Yang XJ (2004) Role of the tetradecapeptide repeat domain of human histone deacetylase 6 in cytoplasmic retention. J Biol Chem 279(46):48246-48254. doi:10.1074/jbc. M408583200
9. Bjorkoy G, Lamark T, Brech A, Outzen H, Perander M, Overvatn A, Stenmark H et al (2005) p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 171(4):603-614. doi:jcb.200507002
10. Boyault C, Gilquin B, Zhang Y, Rybin V, Garman E, Meyer- Klaucke W, Matthias P et al (2006) HDAC6-p97/VCP controlled polyubiquitin chain turnover. EMBO J 25(14):3357-3366. doi:10.1038/sj.emboj.7601210
11. Boyault C, Sadoul K, Pabion M, Khochbin S (2007) HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubiquitination. Oncogene 26(37):5468-5476. doi:10.1038/sj.onc.1210614
12. Boyault C, Zhang Y, Fritah S, Caron C, Gilquin B, Kwon SH, Garrido C et al (2007) HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates. Genes Dev 21(17):2172-2181. doi:10.1101/gad.436407
13. Butler KV, Kalin J, Brochier C, Vistoli G, Langley B, Kozikowski AP (2010) Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A. J Am Chem Soc 132(31):10842-10846. doi:10.1021/ja102758v
14. Chen Y, Klionsky DJ (2011) The regulation of autophagy - unanswered questions. J Cell Sci 124(Pt 2):161-170. doi:10.1242/jcs.064576
15. Chiba Y, Takei S, Kawamura N, Kawaguchi Y, Sasaki K, Hasegawa-Ishii S, Furukawa A et al (2012) Immunohistochemical localization of aggresomal proteins in glial cytoplasmic inclusions in multiple system atrophy. Neuropathol Appl Neurobiol 38(6):559-571. doi:10.1111/j.1365-2990.2011.01229.x
16. Chin SS, Goldman JE (1996) Glial inclusions in CNS degenerative diseases. J Neuropathol Exp Neurol 55(5):499-508
17. Ciechanover A, Brundin P (2003) The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 40(2):427-446
18. Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A, Fraser G et al (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11(7):909-913. doi:10.1038/ncb1901
19. Cohen TJ, Guo JL, Hurtado DE, Kwong LK, Mills IP, Trojanowski JQ, Lee VM (2011) The acetylation of tau inhibits its function and promotes pathological tau aggregation. Nat Commun 2:252. doi:10.1038/ncomms1255
20. Cook C, Gendron TF, Scheffel K, Carlomagno Y, Dunmore J, DeTure M, Petrucelli L (2012) Loss of HDAC6, a novel CHIP substrate, alleviates abnormal tau accumulation. Hum Mol Genet 21(13):2936-2945. doi:10.1093/hmg/dds125
21. Danzer KM, Krebs SK, Wolff M, Birk G, Hengerer B (2009) Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology. J Neurochem 111(1):192-203. doi:10.1111/j.1471-4159.2009.06324.x
22. Dickey CA, Kamal A, Lundgren K, Klosak N, Bailey RM, Dunmore J, Ash P et al (2007) The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. J Clin Invest 117(3):648-658. doi:10.1172/JCI29715
23. Dickson DW, Rademakers R, Hutton ML (2007) Progressive supranuclear palsy: pathology and genetics. Brain Pathol 17(1):74-82. doi:10.1111/j.1750- 3639.2007.00054.x
24. Ding H, Dolan PJ, Johnson GV (2008) Histone deacetylase 6 interacts with the microtubule-associated protein tau. J Neurochem 106(5):2119-2130. doi:10.1111/j.1471-4159.2008.05564.x
25. Ding WX, Yin XM (2008) Sorting, recognition and activation of the misfolded protein degradation pathways through macroautophagy and the proteasome. Autophagy 4(2):141-150
26. Dohm CP, Kermer P, Bahr M (2008) Aggregopathy in neurodegenerative diseases: mechanisms and therapeutic implication. Neurodegener Dis 5(6):321-338. doi:10.1159/000119459
27. Dompierre JP, Godin JD, Charrin BC, Cordelieres FP, King SJ, Humbert S, Saudou F (2007) Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation. J Neurosci 27(13):3571-3583. doi:10.1523/JNEUROSCI.0037-07.2007
28. Esser C, Alberti S, Hohfeld J (2004) Cooperation of molecular chaperones with the ubiquitin/proteasome system. Biochim Biophys Acta 1695(1-3):171-188. doi:10.1016/j.bbamcr.2004.09.020
29. Fellner L, Jellinger KA, Wenning GK, Stefanova N (2011) Glial dysfunction in the pathogenesis of alpha-synucleinopathies: emerging concepts. Acta Neuropathol 121(6):675-693. doi:10.1007/s00401-011-0833-z
30. Fellner L, Stefanova N (2013) The role of glia in alpha- synucleinopathies. Mol Neurobiol 47(2):575-586. doi:10.1007/s12035-012-8340-3
31. Forman MS, Trojanowski JQ, Lee VM (2004) Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 10(10):1055-1063. doi:10.1038/nm1113
32. Frost B, Diamond MI (2010) Prion-like mechanisms in neurodegenerative diseases. Nat Rev Neurosci 11(3):155-159. doi:10.1038/nrn2786
33. Fujita N, Itoh T, Omori H, Fukuda M, Noda T, Yoshimori T (2008) The Atg16L complex specifies the site of LC3 lipidation for membrane biogenesis in autophagy. Mol Biol Cell 19(5):2092-2100. doi:10.1091/mbc.E07-12-1257
34. Fusco C, Micale L, Egorov M, Monti M, D'Addetta EV, Augello B, Cozzolino F et al (2012) The E3-ubiquitin ligase TRIM50 interacts with HDAC6 and p62, and promotes the sequestration and clearance of ubiquitinated proteins into the aggresome. PLoS ONE 7(7):e40440. doi:10.1371/journal.pone.0040440
35. Galpern WR, Lang AE (2006) Interface between tauopathies and synucleinopathies: a tale of two proteins. Ann Neurol 59(3):449-458. doi:10.1002/ana.20819
36. Gamerdinger M, Carra S, Behl C (2011) Emerging roles of molecular chaperones and co-chaperones in selective autophagy: focus on BAG proteins. J Mol Med (Berl) 89(12):1175-1182. doi:10.1007/s00109-011-0795-6
37. Garcia-Mata R, Gao YS, Sztul E (2002) Hassles with taking out the garbage: aggravating aggresomes. Traffic 3(6):388-396
38. Geddes JW (2005) alpha-Synuclein: a potent inducer of tau pathology. Exp Neurol 192(2):244-250. doi:10.1016/j.expneurol.2004.12.002
39. Gendron TF, Petrucelli L (2009) The role of tau in neurodegeneration. Mol Neurodegener 4:13. doi:10.1186/1750-1326-4-13
40. Giasson BI, Forman MS, Higuchi M, Golbe LI, Graves CL, Kotzbauer PT, Trojanowski JQ et al (2003) Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 300(5619):636-640. doi:10.1126/science.1082324
41. Goedert M, Ghetti B, Spillantini MG (2012) Frontotemporal dementia: implications for understanding alzheimer disease. In: Selkoe DJ, Mandelkow E, Holtzmann DM (eds) The biology of alzheimer disease. Cold Spring Harbor Perspectives in Medicine. Cold Spring Harbor Laboratory Press, New York, pp 159-179
42. Goldbaum O, Jensen PH, Richter-Landsberg C (2008) The expression of tubulin polymerization promoting protein TPPP/p25alpha is developmentally regulated in cultured rat brain oligodendrocytes and affected by proteolytic stress. Glia 56(16):1736-1746. doi:10.1002/glia.20720
43. Goldbaum O, Riedel M, Stahnke T, Richter-Landsberg C (2009) The small heat shock protein HSP25 protects astrocytes against stress induced by proteasomal inhibition. Glia 57(14):1566-1577. doi:10.1002/glia.20870
44. Goldbaum O, Vollmer G, Richter-Landsberg C (2006) Proteasome inhibition by MG-132 induces apoptotic cell death and mitochondrial dysfunction in cultured rat brain oligodendrocytes but not in astrocytes. Glia 53(8):891-901. doi:10.1002/glia.20348
45. Gorath M, Stahnke T, Mronga T, Goldbaum O, Richter-Landsberg C (2001) Developmental changes of tau protein and mRNA in cultured rat brain oligodendrocytes. Glia 36(1):89-101
46. Haggarty SJ, Koeller KM, Wong JC, Grozinger CM, Schreiber SL (2003) Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc Natl Acad Sci USA 100(8):4389-4394. doi:10.1073/pnas.0430973100
47. He C, Klionsky DJ (2009) Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 43:67-93. doi:10.1146/annurev-genet-102808-114910
48. Hideshima T, Bradner JE, Wong J, Chauhan D, Richardson P, Schreiber SL, Anderson KC (2005) Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma. Proc Natl Acad Sci USA 102(24):8567-8572. doi:10.1073/pnas.0503221102
49. Himmelstein DS, Ward SM, Lancia JK, Patterson KR, Binder LI (2012) Tau as a therapeutic target in neurodegenerative disease. Pharmacol Ther 136(1):8-22. doi:10.1016/j.pharmthera.2012.07.001
50. Hinault MP, Farina-Henriquez-Cuendet A, Goloubinoff P (2011) Molecular chaperones and associated cellular clearance mechanisms against toxic protein conformers in Parkinson's disease. Neurodegener Dis 8(6):397-412. doi:10.1159/000324514
51. Hong M, Zhukareva V, Vogelsberg-Ragaglia V, Wszolek Z, Reed L, Miller BI, Geschwind DH et al (1998) Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 282(5395):1914-1917
52. Hook SS, Orian A, Cowley SM, Eisenman RN (2002) Histone deacetylase 6 binds polyubiquitin through its zinc finger (PAZ domain) and copurifies with deubiquitinating enzymes. Proc Natl Acad Sci USA 99(21):13425-13430. doi:10.1073/pnas.172511699
53. Huang Q, Figueiredo-Pereira ME (2010) Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications. Apoptosis 15(11):1292-1311. doi:10.1007/s10495-010-0466-z
54. Irwin DJ, Cohen TJ, Grossman M, Arnold SE, Xie SX, Lee VM, Trojanowski JQ (2012) Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies. Brain 135(Pt 3):807-818. doi:10.1093/brain/aws013
55. Iwata A, Riley BE, Johnston JA, Kopito RR (2005) HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin. J Biol Chem 280(48):40282-40292. doi:10.1074/jbc.M508786200
56. Janen SB, Chaachouay H, Richter-Landsberg C (2010) Autophagy is activated by proteasomal inhibition and involved in aggresome clearance in cultured astrocytes. Glia 58(14):1766-1774. doi:10.1002/glia.21047
57. Janke C, Bulinski JC (2011) Post-translational regulation of the microtubule cytoskeleton: mechanisms and functions. Nat Rev Mol Cell Biol 12(12):773-786. doi:10.1038/nrm3227
58. Jellinger KA (2012) Interaction between pathogenic proteins in neurodegenerative disorders. J Cell Mol Med 16(6):1166-1183. doi:10.1111/j.1582-4934.2011.01507.x
59. Jellinger KA, Lantos PL (2010) Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update. Acta Neuropathol 119(6):657-667. doi:10.1007/s00401-010-0672-3
60. Johansen T, Lamark T (2011) Selective autophagy mediated by autophagic adapter proteins. Autophagy 7(3):279-296
61. Johnston JA, Ward CL, Kopito RR (1998) Aggresomes: a cellular response to misfolded proteins. J Cell Biol 143(7):1883-1898
62. Jucker M, Walker LC (2011) Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol 70(4):532-540. doi:10.1002/ana.22615
63. Kalia LV, Kalia SK, McLean PJ, Lozano AM, Lang AE (2013) alpha-Synuclein oligomers and clinical implications for Parkinson disease. Ann Neurol 73(2):155-169. doi:10.1002/ana.23746
64. Kamal A, Boehm MF, Burrows FJ (2004) Therapeutic and diagnostic implications of Hsp90 activation. Trends Mol Med 10(6):283-290. doi:10.1016/j.molmed.2004.04.006
65. Kawaguchi Y, Kovacs JJ, McLaurin A, Vance JM, Ito A, Yao TP (2003) The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115(6):727-738
66. Keller JN, Gee J, Ding Q (2002) The proteasome in brain aging. Ageing Res Rev 1(2):279-293
67. Keller JN, Hanni KB, Markesbery WR (2000) Impaired proteasome function in Alzheimer's disease. J Neurochem 75(1):436-439
68. Kirisako T, Ichimura Y, Okada H, Kabeya Y, Mizushima N, Yoshimori T, Ohsumi M et al (2000) The reversible modification regulates the membrane-binding state of Apg8/Aut7 essential for autophagy and the cytoplasm to vacuole targeting pathway. J Cell Biol 151(2):263-276
69. Kirkin V, Lamark T, Sou YS, Bjorkoy G, Nunn JL, Bruun JA, Shvets E et al (2009) A role for NBR1 in autophagosomal degradation of ubiquitinated substrates. Mol Cell 33(4):505- 516. doi:10.1016/j.molcel.2009.01.020
70. Kirkin V, McEwan DG, Novak I, Dikic I (2009) A role for ubiquitin in selective autophagy. Mol Cell 34(3):259-269. doi:10.1016/j.molcel.2009.04.026
71. Klionsky DJ (2007) Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol 8(11):931-937. doi:10.1038/nrm2245
72. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L et al (2012) Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8(4):445-544
73. Komatsu M, Ichimura Y (2010) Physiological significance of selective degradation of p62 by autophagy. FEBS Lett 584(7):1374-1378. doi:10.1016/j.febslet.2010.02.017
74. Komori T (1999) Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease. Brain Pathol 9(4):663-679
75. Kopito RR (2000) Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 10(12):524-530
76. Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW (2008) Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med 14(5):504-506. doi:10.1038/nm1747
77. Korolchuk VI, Menzies FM, Rubinsztein DC (2010) Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems. FEBS Lett 584(7):1393-1398. doi:10.1016/j.febslet.2009.12.047
78. Kovacs JJ, Murphy PJ, Gaillard S, Zhao X, Wu JT, Nicchitta CV, Yoshida M et al (2005) HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Mol Cell 18(5):601-607. doi:10.1016/j.molcel.2005.04.021
79. Kraft C, Peter M, Hofmann K (2010) Selective autophagy: ubiquitin-mediated recognition and beyond. Nat Cell Biol 12(9):836-841. doi:10.1038/ncb0910-836
80. Kuusisto E, Kauppinen T, Alafuzoff I (2008) Use of p62/SQSTM1 antibodies for neuropathological diagnosis. Neuropathol Appl Neurobiol 34(2):169-180. doi:10.1111/j.1365-2990.2007.00884.x
81. Kuusisto E, Salminen A, Alafuzoff I (2001) Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies. NeuroReport 12(10):2085-2090
82. Kuusisto E, Suuronen T, Salminen A (2001) Ubiquitin-binding protein p62 expression is induced during apoptosis and proteasomal inhibition in neuronal cells. Biochem Biophys Res Commun 280(1):223-228. doi:10.1006/bbrc.2000.4107
83. Lamark T, Johansen T (2010) Autophagy: links with the proteasome. Curr Opin Cell Biol 22(2):192-198. doi:10.1016/j.ceb.2009.11.002
84. Lamark T, Johansen T (2012) Aggrephagy: selective disposal of protein aggregates by macroautophagy. Int J Cell Biol 2012:736905. doi:10.1155/2012/ 736905
85. Lansbury PT Jr (1997) Structural neurology: are seeds at the root of neuronal degeneration? Neuron 19(6):1151-1154
86. Lansbury PT, Lashuel HA (2006) A century-old debate on protein aggregation and neurodegeneration enters the clinic. Nature 443(7113):774-779. doi:10.1038/nature05290
87. Lee JY, Koga H, Kawaguchi Y, Tang W, Wong E, Gao YS, Pandey UB et al (2010) HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy. EMBO J 29(5):969-980. doi:10.1038/emboj.2009.405
88. Lee SJ, Lim HS, Masliah E, Lee HJ (2011) Protein aggregate spreading in neurodegenerative diseases: problems and perspectives. Neurosci Res 70(4):339-348. doi:10.1016/j.neures.2011.05.008
89. Lee VM, Giasson BI, Trojanowski JQ (2004) More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases. Trends Neurosci 27(3):129-134. doi:10.1016/j.tins. 2004.01.007
90. Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, Lashley T et al (2008) Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med 14(5):501-503. doi:10.1038/nm1746
91. Lindersson E, Beedholm R, Hojrup P, Moos T, Gai W, Hendil KB, Jensen PH (2004) Proteasomal inhibition by alpha-synuclein filaments and oligomers. J Biol Chem 279(13):12924- 12934. doi:10.1074/jbc.M306390200
92. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G (2007) Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 8(9):741-752. doi:10.1038/nrm2239
93. Matsuyama A, Shimazu T, Sumida Y, Saito A, Yoshimatsu Y, Seigneurin-Berny D, Osada H et al (2002) In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation. EMBO J 21(24):6820-6831
94. Miki Y, Mori F, Tanji K, Kakita A, Takahashi H, Wakabayashi K (2011) Accumulation of histone deacetylase 6, an aggresome-related protein, is specific to Lewy bodies and glial cytoplasmic inclusions. Neuropathology 31(6):561-568. doi:10.1111/j.1440-1789.2011.01200.x
95. Miller DW, Cookson MR, Dickson DW (2004) Glial cell inclusions and the pathogenesis of neurodegenerative diseases. Neuron Glia Biol 1(1):13-21. doi:10.1017/s1740925x04000043
96. Min SW, Cho SH, Zhou Y, Schroeder S, Haroutunian V, Seeley WW, Huang EJ et al (2010) Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron 67(6):953-966. doi:10.1016/j.neuron.2010.08.044
97. Mizushima N (2007) Autophagy: process and function. Genes Dev 21(22):2861-2873. doi:10.1101/gad.1599207
98. Mizushima N, Kuma A, Kobayashi Y, Yamamoto A, Matsubae M, Takao T, Natsume T et al (2003) Mouse Apg16L, a novel WD-repeat protein, targets to the autophagic isolation membrane with the Apg12-Apg5 conjugate. J Cell Sci 116(Pt 9):1679-1688
99. Mizushima N, Yoshimori T, Levine B (2010) Methods in mammalian autophagy research. Cell 140(3):313-326. doi:10.1016/j.cell.2010.01.028
100. Mollapour M, Neckers L (2012) Post-translational modifications of Hsp90 and their contributions to chaperone regulation. Biochim Biophys Acta 1823(3):648-655. doi:10.1016/j.bbamcr.2011.07.018
101. Mori F, Tanji K, Yoshimoto M, Takahashi H, Wakabayashi K (2002) Demonstration of alpha-synuclein immunoreactivity in neuronal and glial cytoplasm in normal human brain tissue using proteinase K and formic acid pretreatment. Exp Neurol 176(1):98-104
102. Muchowski PJ, Wacker JL (2005) Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 6(1):11-22. doi:10.1038/nrn1587
103. Nixon RA (2006) Autophagy in neurodegenerative disease: friend, foe or turncoat? Trends Neurosci 29(9):528-535. doi:10.1016/j.tins.2006.07.003
104. Odagiri S, Tanji K, Mori F, Miki Y, Kakita A, Takahashi H, Wakabayashi K (2013) Brain expression level and activity of HDAC6 protein in neurodegenerative dementia. Biochem Biophys Res Commun 430(1):394-399. doi:10.1016/j.bbrc.2012. 11.034
105. Olzmann JA, Chin LS (2008) Parkin-mediated K63-linked polyubiquitination: a signal for targeting misfolded proteins to the aggresome-autophagy pathway. Autophagy 4(1):85-87
106. Olzmann JA, Li L, Chin LS (2008) Aggresome formation and neurodegenerative diseases: therapeutic implications. Curr Med Chem 15(1):47-60
107. Palazzo A, Ackerman B, Gundersen GG (2003) Cell biology: tubulin acetylation and cell motility. Nature 421(6920):230. doi:10.1038/421230a
108. Pandey UB, Nie Z, Batlevi Y, McCray BA, Ritson GP, Nedelsky NB, Schwartz SL et al (2007) HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447(7146):859-863. doi:10.1038/nature05853
109. Perez M, Santa-Maria I, Gomez de Barreda E, Zhu X, Cuadros R, Cabrero JR, Sanchez-Madrid F et al (2009) Tau-an inhibitor of deacetylase HDAC6 function. J Neurochem 109(6):1756-1766. doi:10.1111/j.1471-4159.2009.06102.x
110. Petrucelli L, O'Farrell C, Lockhart PJ, Baptista M, Kehoe K, Vink L, Choi P et al (2002) Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons. Neuron 36(6):1007-1019. doi:S089662730201125X
111. Rao R, Fiskus W, Yang Y, Lee P, Joshi R, Fernandez P, Mandawat A et al (2008) HDAC6 inhibition enhances 17-AAG- mediated abrogation of hsp90 chaperone function in human leukemia cells. Blood 112(5):1886-1893. doi:10.1182/blood- 2008-03-143644
112. Reed NA, Cai D, Blasius TL, Jih GT, Meyhofer E, Gaertig J, Verhey KJ (2006) Microtubule acetylation promotes kinesin-1 binding and transport. Curr Biol 16(21):2166-2172. doi:10.1016/j.cub.2006.09.014
113. Reggiori F, Komatsu M, Finley K, Simonsen A (2012) Selective types of autophagy. Int J Cell Biol 2012:156272. doi:10.1155/2012/156272
114. Richter-Landsberg C (2007) Heat shock proteins: expression and functional roles in nerve cells and glia. In: Richter-Landsberg C (ed) Heat shock proteins in neural cells. Landes Bioscience, New York, pp 1-12
115. Richter-Landsberg C (2008) The cytoskeleton in oligodendrocytes. Microtubule dynamics in health and disease. J Mol Neurosci 35(1):55-63. doi:10.1007/s12031-007-9017-7
116. Richter-Landsberg C, Bauer NG (2004) Tau-inclusion body formation in oligodendroglia: the role of stress proteins and proteasome inhibition. Int J Dev Neurosci 22(7):443-451. doi:10.1016/j.ijdevneu.2004.07.003
117. Richter-Landsberg C, Goldbaum O (2003) Stress proteins in neural cells: functional roles in health and disease. Cell Mol Life Sci 60(2):337-349
118. Richter-Landsberg C, Goldbaum O (2007) Small heat shock proteins and the cytoskeleton. In: Richter-Landsberg C (ed) Heat shock proteins in neural cells. Landes Bioscience, New York, pp 13-24
119. Richter-Landsberg C, Gorath M, Trojanowski JQ, Lee VM (2000) alpha-synuclein is developmentally expressed in cultured rat brain oligodendrocytes. J Neurosci Res 62(1):9-14
120. Riedel M, Goldbaum O, Richter-Landsberg C (2009) alpha- Synuclein promotes the recruitment of tau to protein inclusions in oligodendroglial cells: effects of oxidative and proteolytic stress. J Mol Neurosci 39(1-2):226-234. doi:10.1007/s12031-009-9190-y
121. Ross CA, Poirier MA (2004) Protein aggregation and neurodegenerative disease. Nat Med 10(Suppl):S10-S17. doi:10.1038/nm1066
122. Salminen A, Kaarniranta K, Haapasalo A, Hiltunen M, Soininen H, Alafuzoff I (2012) Emerging role of p62/sequestosome-1 in the pathogenesis of Alzheimer's disease. Prog Neurobiol 96(1):87-95. doi:10.1016/j.pneurobio.2011.11.005
123. Schneider A, Mandelkow E (2008) Tau-based treatment strategies in neurodegenerative diseases. Neurotherapeutics 5(3):443-457. doi:10.1016/j.nurt. 2008.05.006
124. Schwartz AL, Ciechanover A (2009) Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology. Annu Rev Pharmacol Toxicol 49:73-96. doi:10.1146/annurev.pharmtox.051208.165340
125. Schwarz L, Goldbaum O, Bergmann M, Probst-Cousin S, Richter-Landsberg C (2012) Involvement of macroautophagy in multiple system atrophy and protein aggregate formation in oligodendrocytes. J Mol Neurosci 47(2):256-266. doi:10.1007/s12031-012-9733-5
126. Sergeant N, Delacourte A, Buee L (2005) Tau protein as a differential biomarker of tauopathies. Biochim Biophys Acta 1739(2-3):179-197. doi:10.1016/j.bbadis.2004.06.020
127. Shahani N, Brandt R (2002) Functions and malfunctions of the tau proteins. Cell Mol Life Sci 59(10):1668-1680
128. Sherman MY, Goldberg AL (2001) Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron 29(1):15-32
129. Simoes-Pires C, Zwick V, Nurisso A, Schenker E, Carrupt PA, Cuendet M (2013) HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs? Mol Neurodegener 8:7. doi:10.1186/1750-1326-8-7
130. Skovronsky DM, Lee VM, Trojanowski JQ (2006) Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Annu Rev Pathol 1:151-170. doi:10.1146/annurev.pathol.1.110304.100113
131. Spires-Jones TL, Stoothoff WH, de Calignon A, Jones PB, Hyman BT (2009) Tau pathophysiology in neurodegeneration: a tangled issue. Trends Neurosci 32(3):150-159. doi:10.1016/j.tins.2008.11.007
132. Stahnke T, Stadelmann C, Netzler A, Bruck W, Richter-Landsberg C (2007) Differential upregulation of heme oxygenase-1 (HSP32) in glial cells after oxidative stress and in demyelinating disorders. J Mol Neurosci 32(1):25-37. doi:JMN:32:1:25
133. Suzuki K, Kirisako T, Kamada Y, Mizushima N, Noda T, Ohsumi Y (2001) The pre-autophagosomal structure organized by concerted functions of APG genes is essential for autophagosome formation. EMBO J 20(21):5971-5981. doi:10.1093/emboj/20.21.5971
134. Tan JM, Wong ES, Kirkpatrick DS, Pletnikova O, Ko HS, Tay SP, Ho MW et al (2008) Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases. Hum Mol Genet 17(3):431-439. doi:10.1093/hmg/ddm320
135. Tanaka K (2009) The proteasome: overview of structure and functions. Proc Jpn Acad Ser B Phys Biol Sci 85(1):12-36. doi: 10.2183/pjab/85.12
136. Tanaka K, Matsuda N (2013) Proteostasis and neurodegeneration: the roles of proteasomal degradation and autophagy. Biochim Biophys Acta. doi:10.1016/j.bbamcr.2013.03.012
137. Tanji K, Odagiri S, Maruyama A, Mori F, Kakita A, Takahashi H, Wakabayashi K (2012) Alteration of autophagosomal proteins in the brain of multiple system atrophy. Neurobiol Dis 49C:190-198. doi:10.1016/j.nbd.2012.08. 017
138. Taylor JP, Tanaka F, Robitschek J, Sandoval CM, Taye A, Markovic- Plese S, Fischbeck KH (2003) Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein. Hum Mol Genet 12(7):749-757
139. True O, Matthias P (2012) Interplay between histone deacetylases and autophagy-from cancer therapy to neurodegeneration. Immunol Cell Biol 90(1):78-84. doi:10.1038/icb.2011.103
140. Tyedmers J, Mogk A, Bukau B (2010) Cellular strategies for controlling protein aggregation. Nat Rev Mol Cell Biol 11(11):777-788. doi:10.1038/nrm2993
141. Verdel A, Curtet S, Brocard MP, Rousseaux S, Lemercier C, Yoshida M, Khochbin S (2000) Active maintenance of mHDA2/mHDAC6 histone-deacetylase in the cytoplasm. Curr Biol 10(12):747-749
142. Waxman EA, Giasson BI (2011) Induction of intracellular tau aggregation is promoted by alpha-synuclein seeds and provides novel insights into the hyperphosphorylation of tau. J Neurosci 31(21):7604-7618. doi:10.1523/JNEUROSCI. 0297-11.2011
143. Wenning GK, Stefanova N, Jellinger KA, Poewe W, Schlossmacher MG (2008) Multiple system atrophy: a primary oligodendrogliopathy. Ann Neurol 64(3):239-246. doi:10.1002/ana.21465
144. W ong E, Cuervo AM (2010) Integration of clearance mechanisms: the proteasome and autophagy. Cold Spring Harb Perspect Biol 2(12):a006734. doi:10.1101/cshperspect.a006734
145. Xiong Y, Zhao K, Wu J, Xu Z, Jin S, Zhang YQ (2013) HDAC6 mutations rescue human tau-induced microtubule defects in Drosophila. Proc Natl Acad Sci USA 110(12):4604-4609. doi:1 0.1073/pnas.1207586110
146. Yao TP (2010) The role of ubiquitin in autophagy-dependent protein aggregate processing. Genes Cancer 1(7):779-786. doi:10.1177/1947601910383277
147. Zhang B, Carroll J, Trojanowski JQ, Yao Y, Iba M, Potuzak JS, Hogan AM et al (2012) The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice. J Neurosci 32(11):3601-3611. doi:10.1523/JNEUROSCI.4922-11.2012
148. Zhang X, Yuan Z, Zhang Y, Yong S, Salas-Burgos A, Koomen J, Olashaw N et al (2007) HDAC6 modulates cell motility by altering the acetylation level of cortactin. Mol Cell 27(2):197- 213. doi:10.1016/j.molcel.2007.05.033
149. Zilberman Y, Ballestrem C, Carramusa L, Mazitschek R, Khochbin S, Bershadsky A (2009) Regulation of microtubule dynamics by inhibition of the tubulin deacetylase HDAC6. J Cell Sci 122(Pt 19):3531-3541. doi:10.1242/jcs. 046813
150. Zilka N, Korenova M, Novak M (2009) Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies. Acta Neuropathol 118(1):71-86. doi:10.1007/s00401-009-0499-y